Michael Scolaro

Michael Scolaro

Oct 11, 2017

Group 6 Copy 61
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Saving lives with synthetic antivenoms: looking for novel solutions to Lonomia envenoming in Colombia

    Venomous caterpillars of the genus Lonomia cause deadly accidents in Colombia. In Brazil it is estimated...

    How to edit any gene.

    Imagine being able to edit any gene—from Alzheimer's and cancer to eye color and balding. Today, that is...

    Making Inexpensive Insulin Using Microalgae

    This page serves as an archive of our first proof-of-concept experiments to genetically modify microalgae...

    Backer Badge Funded